{
  "cik": 1841387,
  "cik_padded": "0001841387",
  "entityName": "Candel Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-103134",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 587000.0,
        "cash": 119731000.0,
        "eps_diluted": -0.72,
        "free_cash_flow": -38898000.0,
        "net_income": -38182000.0,
        "operating_cash_flow": -38311000.0,
        "operating_income": -48266000.0,
        "stockholders_equity": 51922000.0,
        "total_assets": 125195000.0,
        "total_liabilities": 73273000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.411212973306113,
        "roa_avg2y": -0.3290686500532188,
        "roa_period_end": -0.3049802308398898,
        "roe_avg2y": -0.6457898164043671,
        "roe_period_end": -0.7353722892030353
      }
    },
    {
      "accn": "0001193125-26-103134",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 16000.0,
        "cash": 102654000.0,
        "eps_diluted": -1.74,
        "free_cash_flow": -27039000.0,
        "net_income": -55177000.0,
        "operating_cash_flow": -27023000.0,
        "operating_income": -33371000.0,
        "stockholders_equity": 66327000.0,
        "total_assets": 106866000.0,
        "total_liabilities": 40539000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.611199059206658,
        "roa_avg2y": -0.7452977368353516,
        "roa_period_end": -0.5163195029289016,
        "roe_avg2y": -1.3956141238365034,
        "roe_period_end": -0.8318934973690957
      }
    },
    {
      "accn": "0001193125-26-103134",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 457000.0,
        "cash": 35413000.0,
        "eps_diluted": -1.31,
        "free_cash_flow": -34701000.0,
        "net_income": -37939000.0,
        "operating_cash_flow": -34244000.0,
        "operating_income": -38391000.0,
        "stockholders_equity": 12745000.0,
        "total_assets": 41201000.0,
        "total_liabilities": 28456000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 2.232718713220871,
        "roa_avg2y": -0.638209467415806,
        "roa_period_end": -0.9208271643892139,
        "roe_avg2y": -1.2550323359632147,
        "roe_period_end": -2.9767752059631234
      }
    },
    {
      "accn": "0000950170-25-038803",
      "filed": "2025-03-13",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1297000.0,
        "cash": 70058000.0,
        "eps_diluted": -0.65,
        "free_cash_flow": -32716000.0,
        "net_income": -18794000.0,
        "operating_cash_flow": -31419000.0,
        "operating_income": -34722000.0,
        "stockholders_equity": 47714000.0,
        "total_assets": 77691000.0,
        "total_liabilities": 29977000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.6282642411032401,
        "roa_avg2y": -0.2252180998945451,
        "roa_period_end": -0.24190704199971683,
        "roe_avg2y": -0.336054214982432,
        "roe_period_end": -0.3938885861591986
      }
    },
    {
      "accn": "0000950170-24-037637",
      "filed": "2024-03-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1835000.0,
        "cash": 82642000.0,
        "eps_diluted": -1.91,
        "free_cash_flow": -24053000.0,
        "net_income": -36124000.0,
        "operating_cash_flow": -22218000.0,
        "operating_income": -25726000.0,
        "stockholders_equity": 64137000.0,
        "total_assets": 89205000.0,
        "total_liabilities": 25068000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3908508349314748,
        "roa_avg2y": -0.5667087624620549,
        "roa_period_end": -0.4049548792108066,
        "roe_avg2y": -1.78060382008626,
        "roe_period_end": -0.5632318318599249
      }
    },
    {
      "accn": "0000950170-23-010760",
      "filed": "2023-03-30",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1476000.0,
        "cash": 35053000.0,
        "free_cash_flow": -10547000.0,
        "net_income": -17680000.0,
        "operating_cash_flow": -9071000.0,
        "operating_income": -13810000.0,
        "stockholders_equity": -23562000.0,
        "total_assets": 38282000.0,
        "total_liabilities": 12784000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.4618358497466172,
        "roe_avg2y": 1.1189873417721519
      }
    },
    {
      "accn": "0000950170-22-004857",
      "filed": "2022-03-29",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -8038000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-103134",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001841387.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001841387.json"
  },
  "ticker": "CADL"
}